--- title: "Teva Pharmaceuticals USA Inc Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search Teva Pharmaceuticals USA Inc recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/teva-pharmaceuticals-usa-inc/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # Teva Pharmaceuticals USA Inc recall records **29** reported ongoing 51 records in this archive. Latest source date Aug 24, 2026. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Aug 24, 2026 FDA drug enforcement ### [traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Par...](https://isitonrecall.com/recall/fda-drug-d-0834-2026-trazodone-hydrochloride-tablets-usp-50-mg-rx-only-100-tablets-manufactured-in-croatia-by-pliva-hrvat/) Presence of Foreign Tablets/Capsules Class II Reported ongoing Distribution: U.S. Nationwide [Official source for traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pl...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0834-2026%22) Apr 24, 2026 FDA drug enforcement ### [Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL vial of 30 mg strength, a pre-filled syringe containing ...](https://isitonrecall.com/recall/fda-drug-d-0519-2026-octreotide-acetate-for-injectable-suspension-for-gluteal-intramuscular-use-30-mg-in-single-dose-kits/) Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. Class II Reported ongoing Distribution: Nationwide in the USA [Official source for Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dos...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0519-2026%22) Apr 6, 2026 FDA drug enforcement ### [Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs NDC 0555-1054-60; b) 30-count carton, NDC 0555-1054-86, ...](https://isitonrecall.com/recall/fda-drug-d-0521-2026-claravis-isotretinoin-capsule-usp-10-mg-packaged-as-a-100-count-carton-ndc-0555-1054-56-with-10x10-b/) Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin Class II Reported ongoing Distribution: Nationwide in the USA, Puerto Rico and Virgin Islands [Official source for Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, w...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0521-2026%22) Mar 19, 2026 FDA drug enforcement ### [Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT...](https://isitonrecall.com/recall/fda-drug-d-0472-2026-clonidine-transdermal-system-usp-0-1-mg-day-supplied-in-cartons-of-4-systems-and-4-adhesive-covers-r/) CGMP Deviations: use of an unapproved raw material Class II Reported ongoing Distribution: Within U.S [Official source for Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Co...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0472-2026%22) Mar 19, 2026 FDA drug enforcement ### [Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT...](https://isitonrecall.com/recall/fda-drug-d-0473-2026-clonidine-transdermal-system-usp-0-2-mg-day-supplied-in-cartons-of-4-systems-and-4-adhesive-covers-r/) CGMP Deviations: use of an unapproved raw material Class II Reported ongoing Distribution: Within U.S [Official source for Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Co...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0473-2026%22) Mar 19, 2026 FDA drug enforcement ### [Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT...](https://isitonrecall.com/recall/fda-drug-d-0474-2026-clonidine-transdermal-system-usp-0-3-mg-day-supplied-in-cartons-of-4-systems-and-4-adhesive-covers-r/) CGMP Deviations: use of an unapproved raw material Class II Reported ongoing Distribution: Within U.S [Official source for Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Co...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0474-2026%22) Mar 17, 2026 FDA drug enforcement ### [Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S....](https://isitonrecall.com/recall/fda-drug-d-0404-2026-octreotide-acetate-for-injectable-suspension-for-gluteal-intramuscular-use-10-mg-single-dose-8-ml-vi/) Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. Class II Reported ongoing Distribution: Nationwide in the USA [Official source for Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Single-dose 8...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0404-2026%22) Mar 17, 2026 FDA drug enforcement ### [Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S....](https://isitonrecall.com/recall/fda-drug-d-0405-2026-octreotide-acetate-for-injectable-suspension-for-gluteal-intramuscular-use-20-mg-single-dose-8-ml-vi/) Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. Class II Reported ongoing Distribution: Nationwide in the USA [Official source for Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0405-2026%22) Mar 17, 2026 FDA drug enforcement ### [Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S....](https://isitonrecall.com/recall/fda-drug-d-0406-2026-octreotide-acetate-for-injectable-suspension-for-gluteal-intramuscular-use-30-mg-single-dose-8-ml-vi/) Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. Class II Reported ongoing Distribution: Nationwide in the USA [Official source for Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0406-2026%22) Jan 29, 2026 FDA drug enforcement ### [Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,000 tablets bottles (NDC: 45963-709-96), Rx Only, Teva Pharmaceuticals, Parsi...](https://isitonrecall.com/recall/fda-drug-d-0354-2026-metoprolol-succinate-extended-release-tablets-25-mg-100-tablets-bottles-ndc-45963-709-11-and-1-000-t/) Failed Dissolution Specifications Class II Reported ongoing Distribution: Nationwide [Official source for Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0354-2026%22) Jan 29, 2026 FDA drug enforcement ### [Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsi...](https://isitonrecall.com/recall/fda-drug-d-0355-2026-metoprolol-succinate-extended-release-tablets-50-mg-100-tablets-bottles-ndc-45963-676-11-and-1-000-t/) Failed Dissolution Specifications Class II Reported ongoing Distribution: Nationwide [Official source for Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0355-2026%22) Jan 29, 2026 FDA drug enforcement ### [Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceuticals, Pars...](https://isitonrecall.com/recall/fda-drug-d-0356-2026-metoprolol-succinate-extended-release-tablets-rx-only-100-mg-100-tablets-bottles-ndc-45963-677-11-an/) Failed Dissolution Specifications Class II Reported ongoing Distribution: Nationwide [Official source for Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-6...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0356-2026%22) Jan 29, 2026 FDA drug enforcement ### [Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11](https://isitonrecall.com/recall/fda-drug-d-0357-2026-metoprolol-succinate-extended-release-tablets-200-mg-100-tablets-bottles-rx-only-teva-pharmaceutical/) Failed Dissolution Specifications Class II Reported ongoing Distribution: Nationwide [Official source for Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmac...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0357-2026%22) Jan 12, 2026 FDA drug enforcement ### [Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2435-15 (carton), NDC 05...](https://isitonrecall.com/recall/fda-drug-d-0445-2026-isotretinoin-capsules-usp-30-mg-rx-only-10-count-prescription-pack-manufactured-for-teva-pharmaceuti/) Superpotent and Subpotent Class II Reported ongoing Distribution: FL, OH, PR & MS [Official source for Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Ph...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0445-2026%22) Jan 12, 2026 FDA drug enforcement ### [Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 05...](https://isitonrecall.com/recall/fda-drug-d-0446-2026-isotretinoin-capsules-usp-40-mg-10-count-prescription-pacs-rx-only-manufactured-for-teva-pharmaceuti/) Superpotent and Subpotent Class II Reported ongoing Distribution: FL, OH, PR & MS [Official source for Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Ph...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0446-2026%22) Nov 7, 2025 FDA drug enforcement ### [Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distribute...](https://isitonrecall.com/recall/fda-drug-d-0198-2026-carton-label-testosterone-gel-1-2-5-grams-per-unit-dose-ciii-30-unit-dose-packets-rx-only-manufactur/) Defective Container - A defect in the side-seal which allows leakage of product. Class III Reported ongoing Distribution: U.S. Nationwide [Official source for Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0198-2026%22) Oct 13, 2025 FDA drug enforcement ### [Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toro...](https://isitonrecall.com/recall/fda-drug-d-0151-2026-amoxicillin-and-clavulanate-potassium-for-oral-suspension-usp-200-mg-28-5-mg-per-5ml-100-ml-when-rec/) Subpotent drug; Clavulanate Potassium component Class II Reported ongoing Distribution: Distributed in three (3) States: MS, OH, CA. [Official source for Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (wh...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0151-2026%22) Oct 7, 2025 FDA drug enforcement ### [Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4067-01, b) 1000 Capsules, ...](https://isitonrecall.com/recall/fda-drug-d-0104-2026-prazosin-hydrochloride-capsules-usp-1-mg-rx-only-distributed-by-teva-pharmaceuticals-usa-inc-north-w/) CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots. Class II Reported ongoing Distribution: U.S. Nationwide [Official source for Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, IN...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0104-2026%22) Oct 7, 2025 FDA drug enforcement ### [Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4068-01, b) 1000 Capsules, ...](https://isitonrecall.com/recall/fda-drug-d-0105-2026-prazosin-hydrochloride-capsules-usp-2-mg-rx-only-distributed-by-teva-pharmaceuticals-usa-inc-north-w/) CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots. Class II Reported ongoing Distribution: U.S. Nationwide [Official source for Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, IN...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0105-2026%22) Oct 7, 2025 FDA drug enforcement ### [Prazosin Hydrochloride, Capsules, USP, 5 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4069-01, b) 250 Capsules, N...](https://isitonrecall.com/recall/fda-drug-d-0106-2026-prazosin-hydrochloride-capsules-usp-5-mg-rx-only-distributed-by-teva-pharmaceuticals-usa-inc-north-w/) CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots. Class II Reported ongoing Distribution: U.S. Nationwide [Official source for Prazosin Hydrochloride, Capsules, USP, 5 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, IN...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0106-2026%22) ## Reasons in these listed records - Presence of Foreign Tablets/Capsules - Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. - Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin - CGMP Deviations: use of an unapproved raw material These examples come from this result page and are not a ranking of every recall reason. ## Checking Teva Pharmaceuticals USA Inc ### Is there a recall on teva pharmaceuticals usa inc right now? This archive contains 51 records, including 29 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search Teva Pharmaceuticals USA Inc](https://isitonrecall.com/check/?q=Teva%20Pharmaceuticals%20USA%20Inc) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)